Evonik’s production site in Ham, France, goes carbon neutral

Evonik’s production site in Ham, France, goes carbon neutral

Goal of carbon neutrality in Scope 1 and 2 emissions for all Health Care sites by 2030

  • By ICN Bureau | July 14, 2023

Evonik’s production site in Ham in northern France has reduced its direct (Scope 1) and indirect (Scope 2) greenhouse gas emissions to zero. This is the first site from the Health Care business at Evonik to go carbon neutral and underscores the business’s commitment to its goal of becoming carbon neutral in Scope 1 and 2 emissions by 2030.

Evonik Health Care is part of the company’s life sciences division, Nutrition & Care. Guided by a vision that puts sustainability at its core, the division has defined concrete objectives and action plans to achieve carbon neutrality. In the case of the site in Ham, the next phase includes measures and activities to significantly reduce indirect CO2 emissions from supply chains, such as raw materials (Scope 3).

“With this achievement we have taken an important step in our decarbonisation journey. By reducing our footprint, we are providing our customers with the sustainable products they need, while helping to create a healthier, cleaner future for all,” said Thomas Riermeier, head of Evonik’s Health Care business.

Evonik Rexim SAS in Ham, France has been using green electricity since the beginning of 2022. In May this year, the site switched from using natural gas to biogas (biomethane produced from agricultural waste) supplied by local energy company ENGIE. With this new supplier, the site benefits from the well-developed biogas network in northern France.

Register Now to Attend Navigating the Path to Net-zero in the Chemicals Industry on Friday, 26 July 2024

Other Related stories